In macrophages, Ffar4 activation inhibits NFkB signaling and subsequent production of the inflammatory cytokines interleukin-6 and TNFα, rendering these macrophages less inflammatory and attenuating adipocyte dysfunction in obesity (23, 28). Here, FFAR4 is linked to obesity disorder.